Placebo orodispersible tablets clinical trials

Double-blind, randomised, placebo-controlled, phase IIa trial on the efficacy and tolerability of an 8-week treatment with two different doses of budesonide orodispersible tablets vs. placebo for prevention of oesophageal strictures in adult patients after endoscopic submucosal dissection

This study looks at a new medicine called budesonide to see if it can stop a problem called oesophageal strictures. These can happen after a stomach procedure. We're testing two different doses against a dummy pill to see if they work.